Can a novel virus cure heart disease? Check out this NY Times article.

Heart disease is the leading cause of death in the USA, with one in four American’s dying from heart disease according to the CDC (Centers for Disease Control). According to the NY Times. If a company can cure heart disease, they will make their stockholders very wealthy.  The race is on.

The medical literature suggests that the ratio of LDL to HDL if changed reduces cardiac risk which has been the reason statins are frequently recommended.  While this one size fits all approach is what is a common medical practice, those who practice natural or functional medicine have said for years it is actually inflammation that results in heart disease, arterial plaque, and the disease processes causing heart disease.

The NY Times recently reported that a Novel gene editing experiment seems to have permanently reduced LDL and triglyceride levels in monkeys.  If the big pharma approach is correct, this may be an effective way to control cholesterol.   If those from natural medicine are correct, and conventional medicine has realized they are, this may be of little value.

Check out the article from the NY Times

A ‘Cure for Heart Disease’? A Single Shot Succeeds in Monkeys

A novel gene-editing experiment seems to have permanently reduced LDL and triglyceride levels in monkeys.

By Gina Kolata Published June 27, 2020

What if a single injection could lower blood levels of cholesterol and triglycerides — for a lifetime?

In the first gene-editing experiment of its kind, scientists have disabled two genes in monkeys that raise the risk for heart disease. Humans carry the genes as well, and the experiment has raised hopes that a leading killer may one day be tamed.

“This could be the cure for heart disease,” said Dr. Michael Davidson, director of the Lipid Clinic at the University of Chicago Pritzker School of Medicine, who was not involved in the research.

But it will be years before human trials can begin, and gene-editing technology so far has a mixed tracked record. It is much too early to know whether the strategy will be safe and effective in humans; even the monkeys must be monitored for side effects or other treatment failures for some time to come.

Read more